How would I benefit from VesCell™ adult stem cell treatment for heart disease?
The most common form of heart disease is coronary heart disease, which is an ischemia or a reduction of blood flow caused by blockage in the arteries. Over time this reduced flow of blood to the heart muscle causes cardiomyopathy, or actual damage to the heart muscle tissue. If the reduction in blood flow is significant, portions of heart tissue stop functioning altogether. When the damaged area becomes too large, the heart cannot pump blood efficiently and heart failure occurs. Sudden reductions of blood flow to the heart (heart attacks) or a gradual reduction in flow cause chest pains (angina pectoris) and shortness of breath during physical activity. This makes everyday activities like walking or climbing stairs difficult or impossible. As the condition worsens, the patient loses the ability to perform even the simplest physical task. While VesCell™ therapy may not cure heart disease, it can substantially improve the flow of blood to the heart in a large majority of patients. The re
The most common form of heart disease is coronary heart disease, which is an ischemia or a reduction of blood flow caused by blockage in the arteries. Over time this reduced flow of blood to the heart muscle causes cardiomyopathy, or actual damage to the heart muscle tissue. If the reduction in blood flow is significant, portions of heart tissue stop functioning altogether. When the damaged area becomes too large, the heart cannot pump blood efficiently and heart failure occurs. Sudden reductions of blood flow to the heart (heart attacks) or a gradual reduction in flow cause chest pains (angina pectoris) and shortness of breath during physical activity. This makes everyday activities like walking or climbing stairs difficult or impossible. As the condition worsens, the patient loses the ability to perform even the simplest physical task. While VesCell therapy does not cure heart disease, it can substantially improve the flow of blood to the heart in a large majority of patients. The re
